Liposomal amphotericin B therapy of murine histoplasmosis.
Liposomal amphotericin B (AmBisome) was compared with amphotericin B deoxycholate for the treatment of disseminated murine histoplasmosis. Liposomal amphotericin B was well tolerated and, milligram for milligram, was as potent as amphotericin B deoxycholate.
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1995
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486941/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1885 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|